Normal Brain Imaging Database for Brain Disorder Studies (Normal_tDCS)

March 28, 2025 updated by: Ji Hyun Ko, PhD, University of Manitoba
Healthy volunteers will be recruited. All subjects will be tested a battery of neuropsychological tests, then undergo fluorodeoxyglucose-positron emission tomography (PET) and magnetic resonance imaging (MRI). During the PET and MRI, they will be stimulated with transcranial direct current stimulation (tDCS) for 15 minutes. A third of subjects will receive real tDCS on the left prefrontal cortex, a third on the right prefrontal cortex, and the other third will receive sham tDCS.

Study Overview

Status

Active, not recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Manitoba
      • Winnipeg, Manitoba, Canada, R3E 0J9
        • University of Manitoba

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • N/A

Exclusion Criteria:

  • History of any neurological or psychiatric diseases;
  • Abnormal MRI;
  • metal implants or a cardiac pacemaker;
  • Pregnant or breastfeeding women (female subjects of child bearing potential will be screened for pregnancy before MRI imaging).
  • severe hypertension.
  • cardiovascular disease.
  • Family history of epilepsy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Real Left DLPFC tDCS
Real tDCS on the left dorsolateral prefrontal cortex
15 minute anodal stimulation 1.5mA
Sham Comparator: Sham tDCS
30sec ramp-up and 30sec ramp-down
15 minute anodal stimulation 1.5mA
Active Comparator: Real Right DLPFC tDCS
Real tDCS on the right dorsolateral prefrontal cortex
15 minute anodal stimulation 1.5mA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
functional connectivity
Time Frame: immediate (less than 30 minutes)
The functional connectivity of the right caudate nucleus will be estimated using graph theory analysis technique of resting-state fMRI.
immediate (less than 30 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stroop task performance
Time Frame: immediate (less than 60 minutes)
the executive function that is thought to involve the caudate nucleus will be examined
immediate (less than 60 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 28, 2017

Primary Completion (Actual)

March 11, 2020

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

January 16, 2017

First Submitted That Met QC Criteria

January 18, 2017

First Posted (Estimated)

January 23, 2017

Study Record Updates

Last Update Posted (Actual)

April 3, 2025

Last Update Submitted That Met QC Criteria

March 28, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • B2016:074

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on transcranial direct current stimulation

Subscribe